Capital expenditure · 2018–2025
Goodrx Holdings capital expenditure
$3.5M+184.0% · FY2025
Goodrx Holdings (GDRX) reported $3.5M in capital expenditure for fiscal 2025, +184.0% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $3.5M | +184.0% | Open → |
| FY20242024-12-31 | $1.2M | +18.9% | Open → |
| FY20232023-12-31 | $1.0M | −73.7% | Open → |
| FY20222022-12-31 | $4.0M | −13.2% | Open → |
| FY20212021-12-31 | $4.6M | −77.8% | Open → |
| FY20202020-12-31 | $20.6M | +1,342.3% | Open → |
| FY20192019-12-31 | $1.4M | +77.2% | Open → |
| FY20182018-12-31 | $804,000 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +23.5%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Goodrx Holdings capital expenditure |url=https://companiesranked.com/en/company/goodrx-holdings/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Goodrx Holdings capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/goodrx-holdings/capital-expenditureBibTeX
@misc{companiesranked-en-company-goodrx-holdings-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Goodrx Holdings capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/goodrx-holdings/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001809519-26-000031 · February 26, 2026
{{cite web |title=Goodrx Holdings capital expenditure — 10-K (0001809519-26-000031) |url=https://www.sec.gov/Archives/edgar/data/1809519/000180951926000031/gdrx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.